AngioSoma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AngioSoma generated cash of $187,000, which is more than the previous year. Cash used in financing activities reached the amount of $222,500 last year. Net change in cash is therefore -$19,017.
Cash Flow
| 2012 | -285.02K | -280.76K | 545.20K |
|---|---|---|---|
| 2013 | -429.52K | -163.08K | 718.99K |
| 2014 | -311.00K | -139.81K | 324.28K |
| 2015 | -402.45K | -14.26K | 421.19K |
| 2016 | -30K | 5.69K | 30.15K |
| 2017 | -53.74K | 0 | 62K |
| 2018 | -180.09K | -1.41K | 259K |
| 2019 | -260.13K | 0 | 269K |
| 2020 | 187K | -1.78K | 222.5K |
SOAN Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 100.45K | 91.59K | 14.1K | 5.84K | 0 | 1.21K | 127.74K | 1.35K | 21.94K |
Operating activities | |||||||||
Net income | -541.73K | -675.07K | -816.74K | -1.67M | -3.50M | -1.08M | -1.24M | -946.11K | -1.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.32K | 472 | 118 | 0 | 0 | 22.12K | 0 | 61.00K | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 635K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 635K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 650.19K | 911.44K | 305.73K | 0 | 0 | 11.09K | -5.43K | -10.45K | 0 |
Inventories | 37.66K | -36.3K | -3.81K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.6K | 8.52K | 188.08K | 84.96K | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 187K | -260.13K | -180.09K | -53.74K | -30K | -402.45K | -311.00K | -429.52K | -285.02K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -35K | 0 | 0 |
Investments In Property Plant And Equipment | -1.78K | 0 | -1.41K | 0 | 0 | -14.26K | -104.81K | -163.08K | -280.76K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.78K | 0 | -1.41K | 0 | 5.69K | -14.26K | -139.81K | -163.08K | -280.76K |
Financing activities | |||||||||
Common Stock Issued | 500 | 0 | 0 | 30K | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 222.5K | 269K | 259K | 62K | 30.15K | 421.19K | 324.28K | 718.99K | 545.20K |
Net Change In Cash | -19.01K | 8.86K | 77.49K | 8.25K | 5.85K | 4.47K | -126.53K | 126.38K | -20.58K |
Cash at end of period | 81.44K | 100.45K | 91.59K | 14.1K | 5.85K | 5.68K | 1.21K | 127.74K | 1.35K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |